These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 7506183)

  • 21. An evidence-based approach to prescribing NSAIDs in musculoskeletal disease: a Canadian consensus. Canadian NSAID Consensus Participants.
    Tannenbaum H; Davis P; Russell AS; Atkinson MH; Maksymowych W; Huang SH; Bell M; Hawker GA; Juby A; Vanner S; Sibley J
    CMAJ; 1996 Jul; 155(1):77-88. PubMed ID: 8673987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative studies of the risk of serious hepatic injury in persons using nonsteroidal antiinflammatory drugs.
    Walker AM
    Arthritis Rheum; 1997 Feb; 40(2):201-8. PubMed ID: 9041931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Overview of Nonsteroidal Antiinflammatory Drug Reactions.
    Walters KM; Woessner KM
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):625-641. PubMed ID: 27712759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of NSAIDs. An assault on the upper gastrointestinal tract.
    Heigh RI
    Postgrad Med; 1994 Nov; 96(6):63-8. PubMed ID: 7971613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of NSAID complications: gastrointestinal and more.
    Beehrle DM; Evans D
    Lippincotts Prim Care Pract; 1999; 3(3):305-15. PubMed ID: 10711132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs: from phenotyping to genotyping.
    Blanca-López N; Barrionuevo E; Andreu I; Canto MG
    Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):271-7. PubMed ID: 24915547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical implications of NSAID pharmacokinetics: special populations, special considerations.
    Adelizzi RA
    J Am Osteopath Assoc; 1994 May; 94(5):396-8, 401-3. PubMed ID: 8056629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The role of anti-ulcerative drugs in treatment and prevention of gastropathies induced by nonsteroidal anti-inflammatory drugs].
    Fialová P; Vlcek J
    Vnitr Lek; 2004 Nov; 50(11):858-66. PubMed ID: 15648967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Nonsteroidal-anti-inflammatory drugs and serious undesirable gastrointestinal effects].
    Fabijanić D; Kardum D; Banić M; Fabijanić A
    Lijec Vjesn; 2007; 129(6-7):205-13. PubMed ID: 18018712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonsteroidal anti-inflammatory drugs exposure and the central nervous system.
    Auriel E; Regev K; Korczyn AD
    Handb Clin Neurol; 2014; 119():577-84. PubMed ID: 24365321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The value of the clinical history for the diagnosis of immediate nonsteroidal anti-inflammatory drug hypersensitivity and safe alternative drugs in children.
    Topal E; Celiksoy MH; Catal F; Gamze Sayan Y; Sancak R
    Allergy Asthma Proc; 2016; 37(1):57-63. PubMed ID: 26831848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastro-intestinal lesions induced by non-steroidal anti-inflammatory drugs.
    Albu R; Dragomir P; Voiosu R
    Rom J Intern Med; 1998; 36(3-4):145-59. PubMed ID: 10822511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of hypersensitivity reactions to nonsteroidal anti-inflammatory drugs according to the latest classification.
    Demir S; Olgac M; Unal D; Gelincik A; Colakoglu B; Buyukozturk S
    Allergy; 2015 Nov; 70(11):1461-7. PubMed ID: 26173603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypersensitivity Reactions to Non-Steroidal Anti-Inflammatory Drugs.
    Dona I; Salas M; Perkins JR; Barrionuevo E; Gaeta F; Cornejo-Garcia JA; Campo P; Torres MJ
    Curr Pharm Des; 2016; 22(45):6784-6802. PubMed ID: 27779082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile.
    Arellano FM; Yood MU; Wentworth CE; Oliveria SA; Rivero E; Verma A; Rothman KJ
    Pharmacoepidemiol Drug Saf; 2006 Dec; 15(12):861-72. PubMed ID: 17086563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NSAIDs revisited: selection, monitoring, and safe use.
    Amadio P; Cummings DM; Amadio PB
    Postgrad Med; 1997 Feb; 101(2):257-60, 263-7, 270-1. PubMed ID: 9046939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of mucocutaneous reactions in children treated with niflumic acid, other nonsteroidal antiinflammatory drugs, or nonopioid analgesics.
    Sturkenboom M; Nicolosi A; Cantarutti L; Mannino S; Picelli G; Scamarcia A; Giaquinto C;
    Pediatrics; 2005 Jul; 116(1):e26-33. PubMed ID: 15930187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantifying the impact of NSAID-associated adverse events.
    Fine M
    Am J Manag Care; 2013 Nov; 19(14 Suppl):s267-72. PubMed ID: 24494609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unravelling adverse reactions to NSAIDs using systems biology.
    Perkins JR; Sanak M; Canto G; Blanca M; Cornejo-García JA
    Trends Pharmacol Sci; 2015 Mar; 36(3):172-80. PubMed ID: 25577398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonsteroidal antiinflammatory drugs. Renal toxicity. Review of pediatric issues.
    Lindsley CB; Warady BA
    Clin Pediatr (Phila); 1990 Jan; 29(1):10-3. PubMed ID: 2403499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.